Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Enanta Pharmaceuticals (ENTA) Asset Utilization Ratio (2016 - 2025)

Enanta Pharmaceuticals (ENTA) has disclosed Asset Utilization Ratio for 13 consecutive years, with 0.22 as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Asset Utilization Ratio rose 19.55% year-over-year to 0.22, compared with a TTM value of 0.22 through Dec 2025, up 19.55%, and an annual FY2025 reading of 0.2, up 23.26% over the prior year.
  • Asset Utilization Ratio was 0.22 for Q4 2025 at Enanta Pharmaceuticals, down from 0.22 in the prior quarter.
  • Across five years, Asset Utilization Ratio topped out at 0.24 in Q1 2023 and bottomed at 0.17 in Q4 2023.
  • Average Asset Utilization Ratio over 5 years is 0.2, with a median of 0.21 recorded in 2025.
  • The sharpest move saw Asset Utilization Ratio plummeted 42.19% in 2021, then rose 28.74% in 2025.
  • Year by year, Asset Utilization Ratio stood at 0.21 in 2021, then grew by 7.4% to 0.23 in 2022, then decreased by 27.22% to 0.17 in 2023, then increased by 11.09% to 0.18 in 2024, then grew by 19.55% to 0.22 in 2025.
  • Business Quant data shows Asset Utilization Ratio for ENTA at 0.22 in Q4 2025, 0.22 in Q3 2025, and 0.21 in Q2 2025.